Xian Kangda Bio is a provider of cell therapy solutions. The group takes cell therapy as its core industry, and has built CAR-T cell drugs, regenerative medicine, cell preparation and storage, cell technology output, cell quality testing, medical devices, and health management. and other industrial clusters, the business covers the upper, middle and lower reaches of the cell industry, establishing a closed-loop industrial chain of the entire production chain, and creating a complete ecosystem. Recently, it completed the Pre-A round of financing of tens of millions of RMB. This financing was exclusively invested by the funds of Guangdong Lianjing Investment Group Co., Ltd. (“Lianjing Investment”), and the funds raised will be mainly used for team building and the promotion of existing R&D pipelines.
This article is reproduced from: https://www.itjuzi.com/investevent/13265579
This site is for inclusion only, and the copyright belongs to the original author.